Buy Rating Justified by Icon Energy Corp's Strong Financials and Positive Industry Outlook
Icon Price Target Maintained With a $383.00/Share by Truist Securities
Icon Analyst Ratings
Truist Financial Keeps Their Buy Rating on Icon (ICLR)
Maintaining Buy Rating on Icon Stock Amid Unwarranted Selloff and Strong Growth Prospects
Icon Energy Initiated at Buy by Maxim Group
Icon Energy Analyst Ratings
Maxim Group Initiates Coverage On Icon Energy With Buy Rating, Announces Price Target of $7
Truist Financial Remains a Buy on Icon (ICLR)
Icon PLC (ICLR) Maintains Buy Rating: A Strong Financial Outlook Despite Industry Challenges
Icon Price Target Cut to $350.00/Share From $355.00 by Barclays
Icon Analyst Ratings
Truist Adjusts Price Target on ICON to $383 From $367, Maintains Buy Rating
Evercore ISI Remains a Buy on Icon (ICLR)
Buy Rating Affirmed for Icon: Solid Q2 Performance and Promising Financial Outlook
Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), AstraZeneca (AZN) and Icon (ICLR)
Barclays Reaffirms Their Buy Rating on Icon (ICLR)
Icon Analyst Ratings
Icon Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Celcuity (CELC) and Icon (ICLR)
No Data
No Data